Antipsychotic medication and seizures: A review

被引:115
作者
Hedges, D [1 ]
Jeppson, K
Whitehead, P
机构
[1] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA
[2] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA
[3] Utah State Hosp, Provo, UT USA
关键词
D O I
10.1358/dot.2003.39.7.799445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Both first-generation and second-generation antipsychotic medications can lower the seizure threshold, increasing the chances of seizure induction. This article reviews the published literature concerning the seizure-lowering effects of first- and second-generation antipsychotic medication. Unfortunately, rigorously controlled studies are relatively infrequent, and case reports form a large part of the available literature, limiting the confidence with which firm conclusions can be drawn. Of the first-generation antipsychotic medications, chlorpromazine appears to be associated with the greatest risk of seizure provocation, although other first-generation anti-psychotics also lower seizure threshold. Conversely, molindone, haloperidol, fluphenazine, pimozide and trifluoperazine are associated with a lower risk of seizure induction. Clozapine is the second-generation antipsychotic most frequently associated with seizures, with risperidone appearing to confer a relatively low risk. Other factors such as history of seizure activity, concurrent use of other drugs that lower seizure threshold, rapid dose titration, slow drug metabolism, metabolic factors and drug-drug interactions appear to increase the chances of an antipsychotic medication inducing seizure activity. (C) 2003 Prous Science. All rights reserved.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 50 条
[41]   Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication [J].
Moncrieff, Joanna ;
Azam, Kiran ;
Johnson, Sonia ;
Marston, Louise ;
Morant, Nicola ;
Darton, Katherine ;
Wood, Neil .
BMC PSYCHIATRY, 2016, 16
[42]   RISPERIDONE - A NOVEL ANTIPSYCHOTIC MEDICATION [J].
LAND, W ;
SALZMAN, C .
HOSPITAL AND COMMUNITY PSYCHIATRY, 1994, 45 (05) :434-435
[43]   TEA, COFFEE AND ANTIPSYCHOTIC MEDICATION [J].
DARCY, PF .
PHARMACY INTERNATIONAL, 1985, 6 (02) :31-32
[44]   ANTIPSYCHOTIC MEDICATION IN THE TREATMENT OF SCHIZOPHRENIA [J].
KANE, JM .
ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 1995, 32 (01) :30-37
[45]   Predictors of antipsychotic medication change [J].
Sernyak, MJ ;
Leslie, D ;
Rosenheck, R .
JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2005, 32 (01) :85-94
[46]   Dosing the antipsychotic medication olanzapine [J].
Nemeroff, CB .
JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 :45-49
[47]   Choosing a form of antipsychotic medication [J].
Van Dinter, R ;
Flovens, H ;
Roman, B .
SCHIZOPHRENIA RESEARCH, 2006, 81 :99-99
[48]   Facilitating compliance with antipsychotic medication [J].
Marder, SR .
JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 :21-25
[49]   Antipsychotic medication and mortality: A clarification [J].
Weinmann, Stefan ;
Aderhold, Volkmar ;
Read, John .
SCHIZOPHRENIA RESEARCH, 2011, 133 (1-3) :261-261
[50]   Predictors of antipsychotic medication change [J].
Michael J. Sernyak ;
Douglas Leslie ;
Robert Rosenheck .
The Journal of Behavioral Health Services & Research, 2005, 32 :85-94